NMTC
NeuroOne Medical Technologies Corporation
NASDAQHealthcareMedical - DevicesUS
Rating:C-
Company Profile
CEO
David A. Rosa
IPO Date
2018-03-15
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
NeuroOne Medical Technologies Corporation
CEO
David A. Rosa
IPO Date
2018-03-15
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 26,036 |
| $0.80 |
| 7 Apr 2026 | MATHIESEN JEFFREY S | director | A-Award | Acquired | 41,929 | $0.00 |
| 7 Apr 2026 | MATHIESEN JEFFREY S | director | A-Award | Acquired | 26,036 | $0.80 |
| 7 Apr 2026 | BUCKMAN PAUL | director | A-Award | Acquired | 41,929 | $0.00 |
| 7 Apr 2026 | BUCKMAN PAUL | director | A-Award | Acquired | 26,036 | $0.80 |
| 7 Apr 2026 | Andrle Edward | director | A-Award | Acquired | 41,929 | $0.00 |
| 7 Apr 2026 | Andrle Edward | director | A-Award | Acquired | 26,036 | $0.80 |
| 1 Apr 2026 | Christianson Mark | Business Development Director | S-Sale | Disposed | 15,363 | $0.74 |
| 1 Apr 2026 | Christianson Mark | Business Development Director | F-InKind | Disposed | 253 | $0.78 |